COVID-19 associated reduction in elective spay-neuter surgeries for dogs and cats.

The rise in subsidized spay-neuter access helped drive the euthanasia of shelter pets in the US from an estimated 13. 5 million in 1973 to 1.5 million in 2019. When the arrival of the COVID-19 pandemic triggered lockdowns beginning in March 2020, many veterinary providers suspended nonessential services such as routine spay-neuter surgeries. The purpose of this study was to determine the impact of the COVID-19 pandemic on the volume of spay-neuter procedures performed by spay-neuter clinics. A retrospective study of patient data from 212 spay-neuter clinics using Clinic HQ practice management software was conducted from January 2019 through December 2021. The clinics collectively performed 1,217,240 surgeries in the pre-COVID baseline year of 2019. A sharp decline in surgeries began in March 2020 (-22%) and reached a nadir in April 2020 (-80%). Surgeries began to increase in May 2020 (-39%), before plateauing in July 2020 (-6%) and remaining slightly below the 2019 baseline in most months through the end of 2021. Compared to 2019, total surgeries decreased 13% to 1,059,388 in 2020 and decreased 3% to 1,184,274 in 2021. In 2020, when clinic disruptions were highest, the impact of the surgery cutbacks varied by geographic region, species, age, and source of animals. Compared with 2019, in 2020 surgeries decreased 17% in the Midwest region, 15% in the Northeast and West, and 11% in the South. Surgeries were reduced 19% in dogs and 10% in cats. When grouped by age, surgeries were reduced by 18% in geriatrics, 14% in adults, and 11% in juveniles. Reductions were similar for females (-14%) and males (-12%) and similar for unowned/organization-owned animals (-14%) and privately owned animals (-12%). In total, 190,818 fewer surgeries were performed by the 212 studied clinics in the 24 months from January 2020 through December 2021 than would be expected had 2019 levels been maintained. If a similar pattern was experienced by other spay/neuter providers in the US, it would suggest there is a deficit of more than 2.7 million spay/neuter surgeries that animal welfare organizations have yet to address.

Lip Commissure to Eyelid Transposition Flap to Correct Eyelid Agenesis in Cats in a Shelter Setting - a Case Series.

Five cats were diagnosed with eyelid agenesis in a 6-month period at the Miami-Dade Animal Services, and a total of 9 blepharoplasties were performed using the lip commissure to eyelid transposition flap (LCET) technique. Eyelid agenesis affected 50%-80% of the superiolateral lid in all cats. Postoperatively, partial necrosis of the flap was observed in 4 and partial dehiscence was observed in 1 of the corrected eyelids, occurring where the buccal mucosa was sutured to the conjunctival mucosa. No cats with partial necrosis of the flap were known to have developed trichiasis due to scar tissue formed at the necrotic site. The single case in which dehiscence occurred developed slight trichiasis that may warrant further intervention to ensure permanent hair ablation. Eyelids were cosmetically acceptable and functional at final examination. Patients showed no evidence of initial discomfort at the surgical sites, nor discomfort or progression of corneal disease during the follow-up time. This case series documents a suitable technique to treat cat eyelid agenesis when referral to a specialist is not an option due to lack of resources, such as in shelters or low-cost veterinary clinics. The surgical technique, outcome and complications presented in this case series are evaluated, and discussed.

Optimizing heartworm diagnosis in dogs using multiple test combinations.

BACKGROUND: Various heartworm (HW) diagnostic testing modalities detect products of, or reactions to, different life cycle stages of Dirofilaria immitis. Microfilariae (Mf) can be directly visualized in blood, antigen (Ag) from immature and adult heartworms may be detected on commercial assays, and antibody (Ab) tests detect the host immune response to larval stages. Ag and Mf tests are commonly used in dogs, which frequently carry adult HW infections, but Ab tests have only been validated for use in cats. In some HW-infected dogs, Ag is blocked by immune complexing leading to false-negative results. Heat-treatment (HT) to disrupt these complexes can increase the sensitivity of HW Ag tests. The aim of this study was to compare different methods for diagnosing HW infection in dogs at high risk using individual and paired diagnostic tests, including an exploration of using Ab tests designed for cats to test canine samples. METHODS: One hundred stray adult (≥ 2-year-old) dogs in Florida shelters were tested using Mf, HW Ag, and HW Ab tests (feline HW Ab tests currently not commercially validated/approved for use in dogs); two versions of each test platform were used. RESULTS: Fourteen dogs tested positive using point-of-care (POC) Ag tests; an additional 2 dogs tested positive with microtiter well assay, and an additional 12 dogs tested positive using HT Ag testing. For individual tests, Ag test sensitivity/specificity compared to HT Ag was 50-57%/100%, and Ab tests were 46-64%/82-94%. Sensitivity estimates for individual tests were higher when comparing to non-HT Ag. Pairing POC Ag tests with Mf tests improved sensitivity without loss of specificity, while pairing POC Ag and Ab tests modestly increased sensitivity at the expense of specificity. CONCLUSIONS: Screening dogs for HW infection using both POC Ag and Mf detection, which is recommended by the American Heartworm Society, improved diagnostic performance in this study compared to single Ag test use, but may have missed more than one in four infected dogs. The need to improve access to highly accurate, rapid, and inexpensive large-scale HW testing for dogs in animal shelters remains largely unmet by current testing availability. The development of practical and validated protocols that incorporate heat or chemical treatment to disrupt Ag-Ab complexes in POC testing or decreasing the cost and time required for such testing in reference laboratories might provide solutions to this unmet need. Similar studies performed in countries where the prevalence of parasites such as D. repens or A. vasorum is different to the USA could potentially yield very different positive predictive values for both HT and non-HT Ag tests.

Heartworm prevalence in dogs versus cats: Multiple diagnostic modalities provide new insights.

The cornerstones of diagnosis of heartworm (HW) in dogs are the detection of circulating antigen from adult female Dirofilaria immitis or the visualization of microfilariae in whole blood. These tests are less sensitive in cats because of the feline immune response leading to low numbers of adult worms, but heartworm antibody tests are also licensed for use in cats. HW antibodies in cats are detectable when there has at least been larval development in the tissues, but positive antibody tests cannot distinguish between current and previous larval infections; thus, cats with positive antibody test results are considered currently or previously infected with D. immitis. The aim of the present study was to use multiple HW diagnostic modalities to maximize detection of infection in dogs and cats at high risk of infection and to compare infection prevalence between these two hosts. Blood samples collected from 100 stray dogs and 100 stray cats at Florida animal shelters were tested for HW antigen (before and after heat treatment) and microfilariae; cats were also tested for HW antibody. Dogs were significantly (P = 0.0001) more likely to be diagnosed with adult HW infection (28 %; 95 % CI: 20.1-37.6%) when compared with cats (4 %; 95 % CI: 1.6-10.2%) on the basis of positive antigen and microfilariae test results. Cats with current or previous adult, immature adult, or larval HW infections comprised 19 % (95 % CI: 12.4%-27.9%) of the feline population, which was not significantly different (P = 0.1) from the prevalence of adult D. immitis infection in dogs. Testing unprotected cats for heartworm antibodies demonstrated a similar, high risk of infection to the matched unprotected dog population in Florida, which supports the use of HW preventives in cats in areas where HW transmission occurs.

Heartworm prevalence in dogs versus cats: Multiple diagnostic modalities provide new insights.

The cornerstones of diagnosis of heartworm (HW) in dogs are the detection of circulating antigen from adult female Dirofilaria immitis or the visualization of microfilariae in whole blood. These tests are less sensitive in cats because of the feline immune response leading to low numbers of adult worms, but heartworm antibody tests are also licensed for use in cats. HW antibodies in cats are detectable when there has at least been larval development in the tissues, but positive antibody tests cannot distinguish between current and previous larval infections; thus, cats with positive antibody test results are considered currently or previously infected with D. immitis. The aim of the present study was to use multiple HW diagnostic modalities to maximize detection of infection in dogs and cats at high risk of infection and to compare infection prevalence between these two hosts. Blood samples collected from 100 stray dogs and 100 stray cats at Florida animal shelters were tested for HW antigen (before and after heat treatment) and microfilariae; cats were also tested for HW antibody. Dogs were significantly (P = 0.0001) more likely to be diagnosed with adult HW infection (28 %; 95 % CI: 20.1-37.6%) when compared with cats (4 %; 95 % CI: 1.6-10.2%) on the basis of positive antigen and microfilariae test results. Cats with current or previous adult, immature adult, or larval HW infections comprised 19 % (95 % CI: 12.4%-27.9%) of the feline population, which was not significantly different (P = 0.1) from the prevalence of adult D. immitis infection in dogs. Testing unprotected cats for heartworm antibodies demonstrated a similar, high risk of infection to the matched unprotected dog population in Florida, which supports the use of HW preventives in cats in areas where HW transmission occurs.

Teste rápido para detecção da Proteína C-Reativa (FASTest® CRP canino) como auxílio diagnóstico de piometra em cadelas / Fast test for C-reactive Protein detection (FASTest® CRP canine) as an aid for the diagnosis of pyometra in bitches

A piometra é uma enfermidade comum em cadelas, caracterizada pela inflamação do útero com acúmulo de exsudato purulento. A avaliação ultrassonográfica abdominal é um dos principais exames utilizados para o diagnóstico da doença e o tratamento de eleição é a ovário-histerectomia (OSH). A proteína C reativa (PCR) é uma proteína de fase aguda que apresenta concentração sérica aumentada na ocorrência de processos inflamatórios. O objetivo deste trabalho foi avaliar a eficácia do teste rápido para detecção da PCR sérica (FASTest® CRP canino), como auxiliar no diagnóstico de piometra em cadelas com suspeita da doença ao exame ultrassonográfico. Das 25 cadelas com imagem ultrassonográfica sugestiva de piometra incluídas no estudo, apenas 12 (48,0%) tiveram o diagnóstico confirmado por exame histopatológico uterino realizado após a OSH. Em todas as pacientes com o diagnóstico de piometra confirmado pelo exame histológico a PCR foi positiva. O FASTest® CRP apresentou valor preditivo positivo de 92,3%, valor preditivo negativo e sensibilidade de 100,0% e 92,3% de especificidade. Logo, a acurácia do FASTest® CRP canino para diagnóstico de piometra em cadelas com suspeita ao exame ultrassonográfico foi de 96,0%. Conclui-se que o teste rápido para detecção da PCR sérica pode ser utilizado como exame auxiliar para o diagnóstico de piometra em cadelas...

Pyometra is a common disease in bitches characterized by an inflamed uterus filled with pus. Abdominal ultrasonographic evaluation is one of the most requested exam used to diagnose the disease, whereas ovariohysterectomy is the most commonly chosen treatment. C-reactive protein (CRP) is an acute phase protein whose serum concentration increases in inflammatory processes. The goal of this study was to evaluate the effectiveness of the rapid test for detecting serum CRP (FASTest® canine CRP) in the diagnosis of pyometra in bitches with suspicion of the disease by ultrasonography. From 25 bitches with ultrasonographic image suggestive of pyometra included in this study, only 12 (48.0%) has the diagnosis confirmed by histopathological examination of the uterus after ovariohysterectomy. In all patients diagnosed with pyometra, confirmed by histology, the CRP was positive. The FASTest® CRP showed a positive predictive value of 92.3 %, negative predictive value and sensitivity of 100.0% and 92.3% of specificity. Therefore, the accuracy of FASTest® CRP for diagnosis of pyometra in bitches with suspicion by ultrasonography was 96.0%. It was concluded that the rapid test for detecting serum CRP can be used as an aid to diagnose pyometra in bitches...

Subcutaneous administration of paclitaxel in dogs with cancer: A preliminary study.

Intravenous paclitaxel has been underused in dogs due to severe and acute hypersensitivity reactions. Subcutaneous (SC) administration of paclitaxel and its safety are unknown. In this preliminary study, SC administration of paclitaxel was evaluated for hypersensitivity reactions and toxicity in 21 dogs with advanced cancer. Dogs received 1 to 5 paclitaxel doses, ranging from 85 to 170 mg/m(2), SC every 14 or 21 days. A total of 40 paclitaxel doses were administered and none of the 21 dogs developed systemic or acute local hypersensitivity reactions. Severe skin lesions at the injection site developed in 2 dogs after the 4th injection at the same location. Grade 4 neutropenia was observed in 50% of the dogs 5 days after the first treatment at 115 mg/m(2) (n = 14). Two animals developed Grade 5 diarrhea and died likely due to hemodynamic failure or sepsis. Paclitaxel can be administered SC in dogs with no hypersensitivity reaction.

Administration sous-cutanée de paclitaxel chez des chiens atteints du cancer: une étude préliminaire. Le paclitaxel intraveineux a été sous-utilisé chez les chiens en raison de réactions d'hypersensibilité graves et aiguës. L'administration sous-cutanée (SC) de paclitaxel et son innocuité ne sont pas connues. Dans cette étude préliminaire, l'administration SC de paclitaxel a été évaluée pour des réactions d'hypersensibilité et de toxicité chez 21 chiens atteints d'un cancer avancé. Les chiens ont reçu de 1 à 5 doses de paclitaxel, allant de 85 à 170 mg/m2 SC tous les 14 ou 21 jours. Un total de 40 doses de paclitaxel ont été administrées et aucun des 21 chiens n'a développé de réactions d'hypersensibilité systémique ou locale aiguë. Des lésions cutanées graves au site d'injection se sont développées chez deux chiens après la quatrième injection au même endroit. Une neutropénie de grade 4 a été observée chez 50 % des chiens 5 jours après le premier traitement à 115 mg/m2 (n = 14). Deux animaux ont développé une diarrhée de grade 5 et sont morts probablement à cause d'une insuffisance hémodynamique ou d'une sepsie. Le paclitaxel peut être administré SC chez les chiens sans une réaction d'hypersensibilité.(Traduit par Isabelle Vallières).

Surgical placement and management of jugular vascular access ports in dogs and cats: description of technique / Implantación quirúrgica y gestión de catéter venoso central en la vena yugular de perros y gatos: descripción de la técnica / Implante cirúrgico e manejo de cateter venoso central na veia jugular de cães e gatos: descrição da técnica

Background: vascular access ports (VAPs) are designed to allow repeated access to the vascular system with minimum patient distress. Objective: to describe the surgical technique, care and complications of jugular VAPs currently used at the Veterinary Oncology Service of the University of Florida Small Animal Hospital. Conclusion: the VAPs can remain in site for long terms (months) with minimum complications, and its placement is a reliable technique that should be considered by veterinarians, particularly for a longterm treatment.

Antecedentes: los catéteres venosos centrales (VAPs) están diseñados para permitir el acceso repetido al sistema vascular con las mínimas molestias para el paciente. Objetivo: describir la técnica quirúrgica, atención de mantenimiento y las complicaciones de los VAPs en vena yugular, que se utiliza actualmente en el Veterinary Oncology Service en la University of Florida Small Animal Hospital. Conclusión: el VAP puede permanecer en el lugar durante períodos largos (meses) con pocas complicaciones, y su implantación quirúrgica debe ser considerada por los veterinarios, en particular para el tratamiento a largo plazo.

Antecedentes: os cateteres venosos centrais (VAPs) permitem acessos repetidos ao sistema vascular com mínimo desconforto ao paciente. Objetivo: descrever a técnica cirúrgica, cuidados de manutenção e complicações dos VAPs de veia jugular utilizados atualmente no Serviço de Oncologia Veterinária do Hospital Veterinário de Pequenos Animais da Universidade da Florida. Conclusão: o VAP pode permanecer no local por longos períodos (meses) com poucas complicações. O implante cirúrgico descrito no presente trabalho deve ser considerado pelos médicos veterinários, particularmente para tratamentos de longa duração.

Lidocaine prevents referred hyperalgesia associated with cystitis.

AIMS: Lidocaine produces analgesia by inhibiting excitation of nerve endings or blocking impulse conduction in peripheral nerves. This study was performed to determine whether intrathecal or intravesical administration of lidocaine prior, or subsequent, to induction of chemical cystitis in rats would block referred mechanical hyperalgesia. METHODS: Intrathecal or intravesical lidocaine was administered 15 (intrathecal) or 30 (intravesical) min before intravesical instillation of saline or 1 mM acrolein (400 microl) or 4 hr after saline or acrolein instillation in female Wistar rats. Mechanical sensitivity of hind paws was determined at 24 hr prior to any treatment (baseline) and, 4, 24, and 48 hr after intravesical instillation of acrolein or saline. Also, nerve growth factor (NGF) content was measured in bladder and dorsal root ganglia (DRG). RESULTS: Pre-treatment with intrathecal or intravesical lidocaine attenuated acrolein-induced referred mechanical hyperalgesia of the hind paws. Lidocaine administered after acrolein instillation did not alter referred hyperalgesia. Lidocaine treatment prior to or after induction of cystitis reduced NGF content in the bladder. CONCLUSIONS: These results indicate that pre-treatment with lidocaine attenuates referred hyperalgesia associated with cystitis. Lidocaine treatment 4 hr after induction of cystitis failed to prevent referred hyperalgesia despite a similar decrease in bladder NGF. Neurourol. Urodynam. (c) 2009 Wiley-Liss, Inc.

Blockade of NGF and trk receptors inhibits increased peripheral mechanical sensitivity accompanying cystitis in rats.

Visceral inflammation, including that arising from bladder inflammation, reduces the threshold to sensation of innocuous or noxious stimuli applied to peripheral structures (referred hyperalgesia). Cystitis may induce transient or persistent plastic changes mediated by neurotrophins, particularly nerve growth factor (NGF), which contribute to increased nociceptive input. In this study, acute or subacute cystitis was induced in female rats by one or three (at 72-h intervals) 400-microl intravesical instillations of 1 mM acrolein. Sensitivity of the hindpaws to mechanical and thermal stimuli was determined before and 4, 24, 48, 72, and 96 h after treatment. Other groups of rats were treated with intravesical or intrathecal k252a [a nonspecific antagonist of tyrosine kinase (trk) receptors, including trkA, the high-affinity receptor for NGF] before the first or third acrolein instillation. Some rats were intraperitoneally injected with specific NGF-neutralizing antiserum or normal serum before acrolein instillation. Acute and subacute cystitis induced mechanical, but not thermal, referred hyperalgesia that was attenuated by intravesical pretreatment with k252a. Systemic treatment with NGF-neutralizing antiserum before instillation of acrolein suppressed subsequent mechanical referred hyperalgesia. Expression of NGF was increased within the bladder by acute or subacute cystitis and in L6/S1 dorsal root ganglia by subacute cystitis. These results suggest that the bladder-derived NGF acting via trk receptors at least partially mediates peripheral sensitization to mechanical stimuli associated with acute and subacute acrolein-induced cystitis.